does compounded semaglutide cause cancer Semaglutide: What we know about safety and risk Compounded Semaglutide: Why Caution Is

With the right support, you can avoid becoming a statistic and successfully continue on your weight loss journey

Research in Diabetes, Obesity and Metabolism (2023) showed that patients off GLP-1 therapy regained an average of 7 pounds per month during the first year, even with maintained diet and exercise

Tirzepatide (Mounjaro, Zepbound) activates both GLP-1 and GIP receptors, producing stronger weight loss in clinical trialsaveraging 2022% body weight reduction compared to semaglutide's 1518%

The future of peptides In April, the FDA announced that it will hold a meeting in July to consider whether seven peptides should be moved to the list of products that can be compounded